company background image
300147 logo

Xiangxue PharmaceuticalLtd SZSE:300147 Stock Report

Last Price

CN¥12.62

Market Cap

CN¥8.3b

7D

6.9%

1Y

114.6%

Updated

25 Nov, 2024

Data

Company Financials

Xiangxue Pharmaceutical Co.,Ltd.

SZSE:300147 Stock Report

Market Cap: CN¥8.3b

300147 Stock Overview

Xiangxue Pharmaceutical Co., Ltd. engages in the research and development, procurement, manufacture, delivery, and distribution of pharmaceutical products in China. More details

300147 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Xiangxue Pharmaceutical Co.,Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Xiangxue PharmaceuticalLtd
Historical stock prices
Current Share PriceCN¥12.62
52 Week HighCN¥16.49
52 Week LowCN¥3.00
Beta0.52
11 Month Change27.22%
3 Month Change84.50%
1 Year Change114.63%
33 Year Change91.50%
5 Year Change95.05%
Change since IPO30.91%

Recent News & Updates

Xiangxue Pharmaceutical Co.,Ltd. (SZSE:300147) Held Back By Insufficient Growth Even After Shares Climb 36%

Oct 15
Xiangxue Pharmaceutical Co.,Ltd. (SZSE:300147) Held Back By Insufficient Growth Even After Shares Climb 36%

Xiangxue Pharmaceutical Co.,Ltd.'s (SZSE:300147) Shares Bounce 25% But Its Business Still Trails The Industry

Jul 31
Xiangxue Pharmaceutical Co.,Ltd.'s (SZSE:300147) Shares Bounce 25% But Its Business Still Trails The Industry

Recent updates

Xiangxue Pharmaceutical Co.,Ltd. (SZSE:300147) Held Back By Insufficient Growth Even After Shares Climb 36%

Oct 15
Xiangxue Pharmaceutical Co.,Ltd. (SZSE:300147) Held Back By Insufficient Growth Even After Shares Climb 36%

Xiangxue Pharmaceutical Co.,Ltd.'s (SZSE:300147) Shares Bounce 25% But Its Business Still Trails The Industry

Jul 31
Xiangxue Pharmaceutical Co.,Ltd.'s (SZSE:300147) Shares Bounce 25% But Its Business Still Trails The Industry

Benign Growth For Xiangxue Pharmaceutical Co.,Ltd. (SZSE:300147) Underpins Stock's 29% Plummet

Jun 07
Benign Growth For Xiangxue Pharmaceutical Co.,Ltd. (SZSE:300147) Underpins Stock's 29% Plummet

Xiangxue Pharmaceutical Co.,Ltd.'s (SZSE:300147) Price Is Right But Growth Is Lacking After Shares Rocket 38%

Mar 12
Xiangxue Pharmaceutical Co.,Ltd.'s (SZSE:300147) Price Is Right But Growth Is Lacking After Shares Rocket 38%

Shareholder Returns

300147CN PharmaceuticalsCN Market
7D6.9%-1.5%-2.1%
1Y114.6%-9.4%2.8%

Return vs Industry: 300147 exceeded the CN Pharmaceuticals industry which returned -9.4% over the past year.

Return vs Market: 300147 exceeded the CN Market which returned 2.8% over the past year.

Price Volatility

Is 300147's price volatile compared to industry and market?
300147 volatility
300147 Average Weekly Movement17.7%
Pharmaceuticals Industry Average Movement7.4%
Market Average Movement8.4%
10% most volatile stocks in CN Market12.7%
10% least volatile stocks in CN Market5.7%

Stable Share Price: 300147's share price has been volatile over the past 3 months compared to the CN market.

Volatility Over Time: 300147's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of CN stocks.

About the Company

FoundedEmployeesCEOWebsite
19972,644Yonghui Wangwww.xphcn.com

Xiangxue Pharmaceutical Co., Ltd. engages in the research and development, procurement, manufacture, delivery, and distribution of pharmaceutical products in China. It offers antivirotic oral liquids under the Xiangxue brand name; and healthcare supplements, as well as health solutions, such as food and beverage. Xiangxue Pharmaceutical Co., Ltd.

Xiangxue Pharmaceutical Co.,Ltd. Fundamentals Summary

How do Xiangxue PharmaceuticalLtd's earnings and revenue compare to its market cap?
300147 fundamental statistics
Market capCN¥8.35b
Earnings (TTM)-CN¥460.69m
Revenue (TTM)CN¥2.10b

4.0x

P/S Ratio

-18.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300147 income statement (TTM)
RevenueCN¥2.10b
Cost of RevenueCN¥1.51b
Gross ProfitCN¥595.99m
Other ExpensesCN¥1.06b
Earnings-CN¥460.69m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.70
Gross Margin28.32%
Net Profit Margin-21.89%
Debt/Equity Ratio108.6%

How did 300147 perform over the long term?

See historical performance and comparison